TY - JOUR
T1 - Toward a Universal Definition of Etiologies in Heart Failure
T2 - Categorizing Causes and Advancing Registry Science
AU - Agarwal, Anubha
AU - Tromp, Jasper
AU - Almahmeed, Wael
AU - Angermann, Christiane
AU - Chandramouli, Chanchal
AU - Cho, Hyunjai
AU - Choi, Don Ju
AU - Damasceno, Albertino
AU - Filippatos, Gerasimos
AU - Fonarow, Gregg C.
AU - Harikrishnan, Sivadasanpillai
AU - Lund, Lars
AU - Masoudi, Fred
AU - Mensah, George A.
AU - Pathan, Asad
AU - Perel, Pablo
AU - Pinto, Fausto
AU - Ribeiro, Antonio Luiz
AU - Rich, Stuart
AU - Sakata, Yasuhiko
AU - Sliwa, Karen
AU - Sundstrom, Johan
AU - Wong, Renee
AU - Yancy, Clyde
AU - Yiu, Kelvin
AU - Zhang, Jian
AU - Zhang, Yuhui
AU - Lam, Carolyn S.P.
AU - Roth, Gregory A.
N1 - Publisher Copyright:
© 2024 American Heart Association, Inc.
PY - 2024/4/16
Y1 - 2024/4/16
N2 - Heart failure (HF) is a well-described final common pathway for a broad range of diseases however substantial confusion exists regarding how to describe, study, and track these underlying etiologic conditions. We describe (1) the overlap in HF etiologies, comorbidities, and case definitions as currently used in HF registries led or managed by members of the global HF roundtable; (2) strategies to improve the quality of evidence on etiologies and modifiable risk factors of HF in registries; and (3) opportunities to use clinical HF registries as a platform for public health surveillance, implementation research, and randomized registry trials to reduce the global burden of noncommunicable diseases. Investment and collaboration among countries to improve the quality of evidence in global HF registries could contribute to achieving global health targets to reduce noncommunicable diseases and overall improvements in population health.
AB - Heart failure (HF) is a well-described final common pathway for a broad range of diseases however substantial confusion exists regarding how to describe, study, and track these underlying etiologic conditions. We describe (1) the overlap in HF etiologies, comorbidities, and case definitions as currently used in HF registries led or managed by members of the global HF roundtable; (2) strategies to improve the quality of evidence on etiologies and modifiable risk factors of HF in registries; and (3) opportunities to use clinical HF registries as a platform for public health surveillance, implementation research, and randomized registry trials to reduce the global burden of noncommunicable diseases. Investment and collaboration among countries to improve the quality of evidence in global HF registries could contribute to achieving global health targets to reduce noncommunicable diseases and overall improvements in population health.
KW - global health
KW - heart failure
KW - registries
UR - http://www.scopus.com/inward/record.url?scp=85190369640&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.123.011095
DO - 10.1161/CIRCHEARTFAILURE.123.011095
M3 - Review article
C2 - 38626067
AN - SCOPUS:85190369640
SN - 1941-3289
VL - 17
SP - E011095
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 4
ER -